Pfizer is pulling no stops on its Champix marketing campaign in 17 Indian cities—something that worries some doctors that the risks of the drug may get overlooked by consumers. “If the drug is promoted very aggressively to doctors who are not aware of the latest research going on the drug, I’m not sure how it will pan out,” said Vikram Jaggi, medical director at south Delhi-based Asthma, Chest and Allergy Centre, adding that he will prefer to wait for more research on the drug before prescribing it.
But Handa said such concerns are unfounded. “We will be partnering with physicians and corporate hospital chains to set up 600 specialized smoking cessation clinics called Champix Clinics. We are informing the physicians to recognize the risks,” he added. A comprehensive behavioural support programme, called Champs Club, will also be introduced, he said.
Tags - Find More Articles On: